Bionano Genomics Operating Expenses Growth & History (BNGO)
Bionano Genomics's operating expenses was $46.5M for fiscal 2025.
View full Bionano Genomics company overviewBionano Genomics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $46.5M | −$57.8M | −55.42% |
| 2024 | 2024-12-31 | $104.4M | −$120.4M | −53.58% |
| 2023 | 2023-12-31 | $224.8M | $87.2M | +63.33% |
| 2022 | 2022-12-31 | $137.6M | $56.7M | +69.98% |
| 2021 | 2021-12-31 | $81.0M | $39.7M | +95.95% |
| 2020 | 2020-12-31 | $41.3M | $12.1M | +41.34% |
| 2019 | 2019-12-31 | $29.2M | $5.5M | +23.34% |
| 2018 | 2018-12-31 | $23.7M | −$3.0M | −11.20% |
| 2017 | 2017-12-31 | $26.7M | — | — |
Bionano Genomics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.5M | $255,000 | +2.26% |
| Q1 2026 | 2026-03-31 | $11.1M | −$254,000 | −2.23% |
| Q4 2025 | 2025-12-31 | $11.9M | −$3.4M | −22.28% |
| Q3 2025 | 2025-09-30 | $11.9M | −$23.5M | −66.41% |
| Q2 2025 | 2025-06-30 | $11.3M | −$8.3M | −42.47% |
| Q1 2025 | 2025-03-31 | $11.4M | −$22.5M | −66.41% |
| Q4 2024 | 2024-12-31 | $15.4M | −$12.0M | −43.93% |
| Q3 2024 | 2024-09-30 | $35.5M | −$80.5M | −69.43% |
| Q2 2024 | 2024-06-30 | $19.6M | −$21.9M | −52.82% |
| Q1 2024 | 2024-03-31 | $33.9M | −$6.0M | −14.95% |
| Q4 2023 | 2023-12-31 | $27.4M | −$11.9M | −30.36% |
| Q3 2023 | 2023-09-30 | $116.0M | $82.0M | +241.48% |
| Q2 2023 | 2023-06-30 | $41.5M | $8.0M | +23.83% |
| Q1 2023 | 2023-03-31 | $39.9M | $9.1M | +29.57% |
| Q4 2022 | 2022-12-31 | $39.3M | $10.3M | +35.52% |
| Q3 2022 | 2022-09-30 | $34.0M | $12.1M | +55.54% |
| Q2 2022 | 2022-06-30 | $33.5M | $15.6M | +87.27% |
| Q1 2022 | 2022-03-31 | $30.8M | $18.6M | +152.37% |
| Q4 2021 | 2021-12-31 | $29.0M | $16.7M | +135.86% |
| Q3 2021 | 2021-09-30 | $21.8M | $10.9M | +99.14% |
| Q2 2021 | 2021-06-30 | $17.9M | $9.9M | +123.55% |
| Q1 2021 | 2021-03-31 | $12.2M | $2.2M | +21.55% |
| Q4 2020 | 2020-12-31 | $12.3M | $4.0M | +48.99% |
| Q3 2020 | 2020-09-30 | $11.0M | $4.3M | +65.53% |
| Q2 2020 | 2020-06-30 | $8.0M | $550,000 | +7.37% |
| Q1 2020 | 2020-03-31 | $10.0M | $3.2M | +45.73% |
| Q4 2019 | 2019-12-31 | $8.3M | $1.1M | +15.93% |
| Q3 2019 | 2019-09-30 | $6.6M | $893,788 | +15.60% |
| Q2 2019 | 2019-06-30 | $7.5M | $1.9M | +33.55% |
| Q1 2019 | 2019-03-31 | $6.9M | $1.6M | +30.95% |
| Q4 2018 | 2018-12-31 | $7.1M | $535,681 | +8.13% |
| Q3 2018 | 2018-09-30 | $5.7M | −$354,783 | −5.83% |
| Q2 2018 | 2018-06-30 | $5.6M | −$1.7M | −23.62% |
| Q1 2018 | 2018-03-31 | $5.3M | −$1.4M | −21.50% |
| Q4 2017 | 2017-12-31 | $6.6M | — | — |
| Q3 2017 | 2017-09-30 | $6.1M | — | — |
| Q2 2017 | 2017-06-30 | $7.3M | — | — |
| Q1 2017 | 2017-03-31 | $6.7M | — | — |
Bionano Genomics operating expenses trends
Over the last five fiscal years, Bionano Genomics's operating expenses increased from $41.3M to $46.5M, a change of $5.2M. The latest reported quarter, Q2 2026, shows $11.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bionano Genomics source filings ↗